Baricitinib for COVID-19, 16 June 2023
16 June 2023
| Brochure and flyer
Overview
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving remdesivir for non-severe COVID-19.
WHO Team
Editors
World Health Organization
Number of pages
1
Reference numbers
WHO Reference Number: WHO/2019-nCoV/Therapeutics/Baricitinib/Poster_A/2023.1
Copyright
